Devra Barter
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
- Oncology 3
- Neutropenia and Cancer Infections 2
- COVID-19 and healthcare impacts 1
- Co-authors
- Sumanth Gandra (3 shared papers)Ramanan Laxminarayan (3 shared papers)Aude Teillant (1 shared paper)Daniel J. Morgan (1 shared paper)Max Salfinger (1 shared paper)Ruth Lynfield (1 shared paper)Emily Henkle (1 shared paper)Nancy Spina (1 shared paper)
- Journals
- Clinical Infectious Diseases (1 paper)Infection Control and Hospital Epidemiology (1 paper)Open Forum Infectious Diseases (1 paper)The Lancet Infectious Diseases (1 paper)
- Partner nations
- United StatesUgandaUnited Kingdom
In The Last Decade
Devra Barter
5 papers receiving 279 citations
Devra Barter's Hit Papers
Peers
Comparison fields: 5 of 67
- Applied Microbiology and Biotechnology 62
- Molecular Medicine 52
- Microbiology 16
- Clinical Biochemistry 16
- Infectious Diseases 33
Countries citing papers authored by Devra Barter
This map shows the geographic impact of Devra Barter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devra Barter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devra Barter more than expected).
Fields of papers citing papers by Devra Barter
This network shows the impact of papers produced by Devra Barter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devra Barter. The network helps show where Devra Barter may publish in the future.
Co-authors
The 25 scholars most cited alongside Devra Barter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study Hit paper breakdown → | 2015 | 261 |
| 2 | 2023 | 24 | |
| 3 | Insulin access for Africa : Cape Town declaration of action 2016 : diabetes | 2016 | 2 |
| 4 | Saving Diabetic Feet in Africa : Cape Town action declaration 2016 : diabetes | 2016 | 1 |
| 5 | 2018 | 1 | |
| 6 | 2020 | 0 |
About Devra Barter
Devra Barter is a scholar working on Oncology, Epidemiology, Endocrinology, Diabetes and Metabolism, Infectious Diseases and Surgery, having authored 6 papers that have together received 289 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (2 papers), Diabetes Management and Research (1 paper), Surgical site infection prevention (1 paper), HIV/AIDS oral health manifestations (1 paper), Antifungal resistance and susceptibility (1 paper), Wound Healing and Treatments (1 paper), Global Public Health Policies and Epidemiology (1 paper) and COVID-19 and healthcare impacts (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (62 citations), Molecular Medicine (52 citations), Microbiology (16 citations), Clinical Biochemistry (16 citations) and Infectious Diseases (33 citations). Devra Barter has collaborated with scholars based in United States, Uganda and United Kingdom. Frequent co-authors include Sumanth Gandra, Ramanan Laxminarayan, Aude Teillant, Daniel J. Morgan, Max Salfinger, Ruth Lynfield, Emily Henkle, Nancy Spina, Rebecca Pierce and Shelley S. Magill. Their work appears in journals such as Clinical Infectious Diseases, Infection Control and Hospital Epidemiology, Open Forum Infectious Diseases and The Lancet Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.